Navigation Links
Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
Date:5/30/2008

such statements. These risks and uncertainties include, without limitation, the inherent uncertainty of the timing and success of, and expense associated with, research, development, regulatory approval and commercialization of our products and pipeline products; government cost- containment initiatives; restrictions on third-party payments for our products; substantial competition in our industry, including from branded and generic products; emerging data on our products and pipeline products; the importance of strong performance from our principal products and our anticipated new product introductions; the highly regulated nature of our business; product liability, intellectual property and other litigation risks and environmental liabilities; uncertainty regarding our intellectual property rights and those of others; difficulties associated with, and regulatory compliance with respect to, manufacturing of our products; risks associated with our strategic relationships; economic conditions including interest and currency exchange rate fluctuations; changes in generally accepted accounting principles; trade buying patterns; the impact of legislation and regulatory compliance; risks and uncertainties associated with global operations and sales; and other risks and uncertainties, including those detailed from time to time in our periodic reports filed with the Securities and Exchange Commission, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual report on Form 10-K, particularly the discussion under the caption "Item 1A, Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2007, which was filed with the Securities and Exchange Commission on February 29, 2008. The forward-looking statements in this press release are qualified by these risk factors. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

Note
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia
2. Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers
3. Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis
4. Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations
5. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
6. Wyeths TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
7. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
8. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
9. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
10. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
11. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... TUSTIN, Calif. , March 5, 2015  BioPhotas, ... energy products that use patented photo-therapeutic technologies to treat ... has partnered with the Semper Fi Fund to provide ... members in need of pain management solutions.  ... reported, "The first Marine who used the Celluma at ...
(Date:3/5/2015)... CANTEL MEDICAL CORP. (NYSE: CMN ) ... 31, 2015 on Thursday, March 12 before the market opens, ... 11:00 AM ET. To participate in the ... before the beginning of the call. If you are unable ... available from Thursday, March 12, 2015 through midnight on May ...
(Date:3/5/2015)... 5, 2015   ndd Medical Technologies , a ... employs precise ultrasound technology, announced that its EasyOne Pro® ... the San Antonio Pulmonary Fibrosis Support Group. The clinic ... fibrosis (PF), as well as those suspected of having ... a mere 12 square inches, EasyOne Pro provides accurate ...
Breaking Medicine Technology:BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 3Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January 31, 2015 2ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 2ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 3
... resistant Staphylococcus aureus (MSSA, MRSA) can cause ... septicemia, endocarditis, and pneumonia. Healthcare associated ... it is not only predictably cross resistant ... also typically resistant to multiple other antibiotics. ...
... in the context of many clinical laboratories, automated production ... many years. In automobile assembly, for example, automated lines ... oversight. The result has been vastly improved products, far ... productivity. These days, only a handful of luxury and ...
Cached Medicine Technology:Controlling the Spread of Healthcare Associated Methicillin Resistant Staphylococcus aureus Requires Active Surveillance 2Controlling the Spread of Healthcare Associated Methicillin Resistant Staphylococcus aureus Requires Active Surveillance 3Lab Automation Networks Proliferating 2Lab Automation Networks Proliferating 3Lab Automation Networks Proliferating 4
(Date:3/6/2015)... Many patients with knee osteoarthritis have continued pain ... someone you know) have chronic pain and problems with ... in the ACT-OA clinical trial. , Kevin Darr, ... one of fifteen physicians in the U.S. to receive ... part of a new, multi-site, double blind, placebo-controlled clinical ...
(Date:3/6/2015)... In a new study conducted at a Warsaw ... shoulder pain was their first mesothelioma symptom. Surviving Mesothelioma has ... here to read it now. , Doctors at the ... 49 mesothelioma patients between 2006 and 2012 and ... pain that first prompted them to see a doctor. For ...
(Date:3/6/2015)... 06, 2015 Los Angeles cosmetic dentist ... for Zoom whitening. Zoom is a special type of teeth ... Unlike other teeth whitening treatments, Zoom does its job in ... stains. For a limited time, Dr. Ghasri is offering Zoom ... usual price of $650 and allows patients to try out ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 As the ... to be discussed, Ford & Associates Nationwide Legal Services, ... January 2015 filed lawsuit: Verduzco v. Daiichi Sankyo, Inc., ... of California. , “In light of a recently ... used Benicar to evaluate and explore the Mayo Clinic's ...
(Date:3/5/2015)... New York, NY (PRWEB) March 05, 2015 ... first time in more than a decade. She has hinted ... not want to miss seeing her perform one last time. ... two years and this beloved country sweetheart has millions of loyal ... be touring throughout her native country, Canada, and on June 30th ...
Breaking Medicine News(10 mins):Health News:Kevin Darr, M.D. is Now Enrolling Patients in a New FDA-Approved Clinical Trial Evaluating Adipose-Derived Regenerative Cells in the Treatment of Knee Osteoarthritis 2Health News:New Report Reveals Shoulder Pain Could Signal Early Mesothelioma, According to Surviving Mesothelioma 2Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, is Now Offering a Promotion on Zoom Whitening 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 4Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 2Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 3
... personal injury lawyer reacts to hard-hitting New York Times investigative series that ... New York state. , ... New York, NY (PRWEB) April 7, 2009 ... of their own much-needed workers, compensation claim rather than face ...
... encryption services DALLAS, April 7 Zix Corporation ... in email encryption services, today announced that Houston ... three-year contract for the company,s email encryption services.ZixCorp ... ensure the secure handling of confidential information. The ...
... DARTMOUTH, NS, April 7 /PRNewswire/ - A new study ... AACR (American Association for Clinical Cancer Research), shows diets ... acid) may decrease the risk of prostate cancer. This ... with a genetic tendency towards developing the disease. , ...
... Andersen Consulting and Siebel Systems involved with new independent ... new company aimed at promoting and supporting a home-centered ... George T. Shaheen as a member of the company,s ... George has accepted a position on our Board and ...
... ... Atlanta, GA & Las Vegas, NV (PRWEB) April 7, ... outsourcing, today announced it has formed a strategic relationship with Oval ... comprehension and decision making of Intellectual Property landscapes. The solution ...
... that female noses are more sensitive to body odors , , ... fancy colognes and detect male body odor, but men don,t ... speculate that women may be more sensitive to biologically relevant ... a mate. , "It is quite difficult to block a ...
Cached Medicine News:Health News:Workers Comp Troubles Making You Sick? New York Personal Injury Lawyers Might Just Have the Cure 2Health News:Workers Comp Troubles Making You Sick? New York Personal Injury Lawyers Might Just Have the Cure 3Health News:Workers Comp Troubles Making You Sick? New York Personal Injury Lawyers Might Just Have the Cure 4Health News:Zix Corporation Selected by Houston Healthcare for Email Encryption Service 2Health News:Omega-3 EPA/DHA May Decrease Risk of Developing Prostate Cancer 2Health News:Omega-3 EPA/DHA May Decrease Risk of Developing Prostate Cancer 3Health News:George T. Shaheen Joins Board of Directors at Univita Health 2Health News:UnitedLex Announces Strategic Alliance with Oval Ideas to Enable Superior Patent Analytics 2Health News:What's That Smell? Ask a Woman, Not a Man 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: